Phase 1/2 study of cetuximab plus capecitabine in elderly patients with kras-wild type mCRC who have no prior chemotherapy
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: capecitabine,cetuximab Primary outcome(s): Safety/efficacy Study Design: Single arm Non-randomized
创建时间：
2010-11-15
